Research Article
The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
Table 1
Clinicopathological characteristics of esophageal squamous cell carcinoma patients (
(%)).
| Characteristics and finding | |
| Age (years old) | 63.53 (38-83) | Tumor size (cm) | 3.81 (1-8.5) | Gender | | Male | 129 (75) | Female | 43 (25) | Race | | Han | 94 (54.7) | Kazak | 78 (45.3) | Tumor site | | Upper | 8 (4.7) | Middle | 95 (55.2) | Lower | 69 (40.1) | Differentiation | | Well | 33 (19.2) | Moderate | 97 (56.4) | Poor | 42 (24.4) | pTNM | | IB | 12 (7) | IIA,B | 86 (50) | IIIA,B,C | 74 (43) | Lymph metastasis | | Negative | 113 (65.7) | Positive | 59 (34.3) | Vessel invasion | | Negative | 141 (82) | Positive | 31 (18) | Nerve invasion | | Negative | 136 (79.1) | Positive | 36 (20.9) | Distant metastases | | Negative | 132 (76.7) | Positive | 40 (23.3) | Treatment | | Surgery | 109 (63.4) | Postoperative chemoradiotherapy | 63 (36.6) | FGF2 | | Low expression | 55 (32) | High expression | 117 (68) | FGFR3 | | Low expression | 61 (35.5) | High expression | 111 (64.5) | FGFBP1 | | Low expression | 60 (34.9) | High expression | 112 (65.1) |
|
|